The Q4 result was announced on Saturday, 9 May 2015.

Meanwhile, the S&P BSE Sensex was up 344.25 points or 1.27% at 27,450.22.

On BSE, so far 54,000 shares were traded in the counter as against average daily volume of 20,031 shares in the past one quarter.

The stock hit a high of Rs 208.45 and a low of Rs 186.60 so far during the day. The stock had hit a 52-week high of Rs 267.90 on 15 December 2014. The stock had hit a 52-week low of Rs 182 on 14 July 2014.

The stock had outperformed the market over the past one month till 8 May 2015, sliding 4.99% compared with Sensex's 5.58% fall. The scrip had also outperformed the market in past one quarter, declining 3.19% as against Sensex's 5.62% fall.

The small-cap company has equity capital of Rs 18.15 crore. Face value per share is Rs 2.

The bottom line during the quarter was pulled down by lower other income. Other income dropped 77.5% to Rs 5.51 crore in Q4 March 2015 over Q4 March 2014.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company.